Page 86 - Depression in adults: treatment and management
P. 86
Depression in adults: treatment and management (NG222)
Rationale and impact Rationale and impact
These sections briefly explain why the committee made the recommendations and how they might
affect practice or services.
Choice of treatments Choice of treatments
Recommendations 1.3.1 to 1.3.6
Why the committee made the recommendations Why the committee made the recommendations
The evidence showed that both people with depression and healthcare professionals want time to
engage in meaningful discussions and to build trusting relationships with healthcare professionals
who they feel comfortable with, so that people with depression can be actively involved in decision
making about treatment options and choices. There was evidence that people's involvement in
making choices about their treatment may be impacted by preconceptions about different
treatment options, the depression symptoms themselves, and the resources available.
How the recommendations might affect practice How the recommendations might affect practice
Offering people choice of treatments and discussing treatment options may mean longer
consultation times are needed, and this may have a resource impact for the NHS. However,
providing information about choices is likely to lead to improved adherence with therapy and
better outcomes for people with depression, offsetting any costs associated with longer
consultations.
Return to recommendations
Starting and stopping antidepressants Starting and stopping antidepressants
Recommendations 1.4.10 to 1.4.23
Why the committee made the recommendations Why the committee made the recommendations
The committee reviewed the evidence on antidepressants identified as part of the development of
the NICE guideline on safe prescribing, and used this together with their knowledge and experience
to develop recommendations.
© NICE 2022. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- Page 86 of
conditions#notice-of-rights). 103
